Honglei Chen

Author PubWeight™ 312.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 56.72
2 A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 50.94
3 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 41.47
4 Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 26.95
5 Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012 11.32
6 The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013 10.43
7 Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009 10.34
8 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015 7.99
9 Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015 6.13
10 SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009 3.55
11 Pesticide exposure and risk for Parkinson's disease. Ann Neurol 2006 2.89
12 Use of ibuprofen and risk of Parkinson disease. Neurology 2011 2.70
13 Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke 2005 2.63
14 Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet 2011 2.28
15 Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord 2007 2.24
16 Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 2007 1.97
17 Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev 2009 1.91
18 Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality. Am J Epidemiol 2009 1.87
19 Diabetes and risk of Parkinson's disease. Diabetes Care 2011 1.80
20 Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol 2008 1.69
21 Bone mineral density and dietary patterns in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr 2002 1.61
22 The outdoor air pollution and brain health workshop. Neurotoxicology 2012 1.60
23 Both low and high temperature may increase the risk of stroke mortality. Neurology 2013 1.59
24 Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 2007 1.57
25 Multivitamin use and telomere length in women. Am J Clin Nutr 2009 1.54
26 Head injury and Parkinson's disease: a population-based study. Mov Disord 2012 1.52
27 Recreational physical activity and risk of Parkinson's disease. Mov Disord 2008 1.45
28 Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology 2011 1.45
29 Day napping and short night sleeping are associated with higher risk of diabetes in older adults. Diabetes Care 2009 1.37
30 Diurnal temperature range and daily mortality in Shanghai, China. Environ Res 2007 1.35
31 Telomere length and risk of Parkinson's disease. Mov Disord 2008 1.31
32 Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol 2012 1.28
33 Comparative analysis of the first complete Enterococcus faecium genome. J Bacteriol 2012 1.27
34 Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003 1.26
35 Novel phlebovirus with zoonotic potential isolated from ticks, Australia. Emerg Infect Dis 2014 1.21
36 Erectile function and risk of Parkinson's disease. Am J Epidemiol 2007 1.15
37 Daytime napping, nighttime sleeping, and Parkinson disease. Am J Epidemiol 2011 1.12
38 Complete genome sequence of the frog pathogen Mycobacterium ulcerans ecovar Liflandii. J Bacteriol 2012 1.08
39 Intestinal microbiota associated with differential feed conversion efficiency in chickens. Appl Microbiol Biotechnol 2012 1.08
40 Body mass index and the risk of dementia among Louisiana low income diabetic patients. PLoS One 2012 1.07
41 Alcohol consumption and the incidence of Parkinson's disease. Ann Neurol 2003 1.05
42 The tau gene haplotype h1 confers a susceptibility to Parkinson's disease. Eur Neurol 2004 1.04
43 Plasma urate and Parkinson's disease in women. Am J Epidemiol 2010 1.03
44 Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer. PLoS One 2013 0.99
45 Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study. Mov Disord 2010 0.99
46 Blood donations, iron stores, and risk of Parkinson's disease. Mov Disord 2006 0.98
47 Complete genome sequence of Staphylococcus aureus strain JKD6159, a unique Australian clone of ST93-IV community methicillin-resistant Staphylococcus aureus. J Bacteriol 2010 0.98
48 Comparative analyses of Legionella species identifies genetic features of strains causing Legionnaires' disease. Genome Biol 2014 0.98
49 A prospective study of bowel movement frequency and risk of Parkinson's disease. Am J Epidemiol 2011 0.98
50 Comparative analysis of the complete genome of an epidemic hospital sequence type 203 clone of vancomycin-resistant Enterococcus faecium. BMC Genomics 2013 0.98
51 Autophagic tumor stroma: mechanisms and roles in tumor growth and progression. Int J Cancer 2012 0.98
52 Population genomics and phylogeography of an Australian dairy factory derived lytic bacteriophage. Genome Biol Evol 2012 0.97
53 Infection of the central nervous system, sepsis and amyotrophic lateral sclerosis. PLoS One 2011 0.95
54 Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect 2008 0.94
55 Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study. Mov Disord 2015 0.93
56 The prognostic value of autophagy-related markers beclin-1 and microtubule-associated protein light chain 3B in cancers: a systematic review and meta-analysis. Tumour Biol 2014 0.92
57 Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance. Eur J Cardiothorac Surg 2008 0.92
58 Calcium channel blocker use and risk of Parkinson's disease. Mov Disord 2010 0.90
59 An exploratory analysis on gene-environment interactions for Parkinson disease. Neurobiol Aging 2012 0.90
60 Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease. Mov Disord 2009 0.90
61 Chinese culture permeation in the treatment of Parkinson disease: a cross-sectional study in four regions of China. BMC Res Notes 2014 0.90
62 Multivitamins, individual vitamin and mineral supplements, and risk of diabetes among older U.S. adults. Diabetes Care 2010 0.89
63 Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium. J Biomed Sci 2010 0.89
64 Paracrine action of HO-1-modified mesenchymal stem cells mediates cardiac protection and functional improvement. Cell Biol Int 2008 0.89
65 An exploratory study on the CHRNA3-CHRNA5-CHRNB4 cluster, smoking, and Parkinson's disease. Neurodegener Dis 2011 0.88
66 Perceived imbalance and risk of Parkinson's disease. Mov Disord 2008 0.88
67 Caveolin-1 and VEGF-C promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer. Tumori 2011 0.87
68 Dietary iron intake and risk of Parkinson's disease. Am J Epidemiol 2008 0.87
69 Serum cholesterol and the progression of Parkinson's disease: results from DATATOP. PLoS One 2011 0.86
70 Functional similarities between pigeon 'milk' and mammalian milk: induction of immune gene expression and modification of the microbiota. PLoS One 2012 0.86
71 No association between Parkinson disease alleles and the risk of melanoma. Cancer Epidemiol Biomarkers Prev 2011 0.86
72 Apolipoprotein E genotypes and the risk of Parkinson disease. Neurobiol Aging 2011 0.86
73 Parkinson's disease and cancer: A register-based family study. Am J Epidemiol 2013 0.85
74 Epidemiology and clinical phenomenology for Parkinson's disease with pain and fatigue. Parkinsonism Relat Disord 2012 0.85
75 Heart rate variability and the risk of Parkinson disease: The Atherosclerosis Risk in Communities study. Ann Neurol 2015 0.84
76 Prenatal and early life factors and risk of Parkinson's disease. Mov Disord 2010 0.84
77 Serum cholesterol and nigrostriatal R2* values in Parkinson's disease. PLoS One 2012 0.83
78 Associations of Ozone and PM2.5 Concentrations With Parkinson's Disease Among Participants in the Agricultural Health Study. J Occup Environ Med 2015 0.82
79 Thiamine nutritional status and depressive symptoms are inversely associated among older Chinese adults. J Nutr 2012 0.82
80 Female reproductive factors, menopausal hormone use, and Parkinson's disease. Mov Disord 2013 0.82
81 Caffeinated clues from epidemiology of Parkinson's disease. Neurology 2003 0.81
82 Stock volatility as a risk factor for coronary heart disease death. Eur Heart J 2010 0.81
83 CNS infections, sepsis and risk of Parkinson's disease. Int J Epidemiol 2012 0.81
84 128 × 128 long-wavelength/mid-wavelength two-color HgCdTe infrared focal plane array detector with ultralow spectral cross talk. Opt Lett 2014 0.80
85 Accuracy of residential geocoding in the Agricultural Health Study. Int J Health Geogr 2014 0.80
86 Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer. Int J Mol Sci 2012 0.80
87 Ambient Air Pollution Exposures and Risk of Parkinson Disease. Environ Health Perspect 2016 0.79
88 History of smoking and olfaction in Parkinson's disease. Mov Disord 2014 0.79
89 Alcohol Consumption, Types of Alcohol, and Parkinson's Disease. PLoS One 2013 0.79
90 An exploratory study on CLU, CR1 and PICALM and Parkinson disease. PLoS One 2011 0.78
91 Circulating melatonin levels: possible link between Parkinson's disease and cancer risk? Cancer Causes Control 2006 0.78
92 Prospective research on Parkinson nonmotor symptoms. Arch Neurol 2011 0.78
93 Short communication: genetic variations of SLC2A9 in relation to Parkinson's disease. Transl Neurodegener 2013 0.77
94 Ligasure versus Ferguson hemorrhoidectomy in the treatment of hemorrhoids: a meta-analysis of randomized control trials. Surg Laparosc Endosc Percutan Tech 2015 0.77
95 Uric acid correlates to oxidation and inflammation in opposite directions in women. Biomarkers 2015 0.77
96 HIV infection accelerates gastrointestinal tumor outgrowth in NSG-HuPBL mice. AIDS Res Hum Retroviruses 2014 0.76
97 Agricultural exposures and stroke mortality in the Agricultural Health Study. J Toxicol Environ Health A 2013 0.76
98 [Microdissection and PCR-SSCP detected mutation and expression of p53 and K-ras gene in carcinogenesis and development of induced rat lung carcinoma]. Zhonghua Bing Li Xue Za Zhi 2002 0.76
99 Dietary fat intake and risk for Parkinson's disease. Mov Disord 2014 0.76
100 The effect of acupuncture on plasma endothelin content in cerebral infarction patients--a clinical study. J Tradit Chin Med 2007 0.75
101 Proteomic analysis of serum in lung cancer induced by 3-methylcholanthrene. J Biomed Biotechnol 2009 0.75
102 Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults. Medicine (Baltimore) 2015 0.75
103 Reply: Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent? Mov Disord 2010 0.75
104 [Different expressions of p53 gene family members and their clinical significance in human non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 2004 0.75
105 Relative Contributions of Agricultural Drift, Para-Occupational, and Residential Use Exposure Pathways to House Dust Pesticide Concentrations: Meta-Regression of Published Data. Environ Health Perspect 2016 0.75
106 Downregulation of gene expression and activity of GRIM-19 affects mouse oocyte viability, maturation, embryo development and implantation. J Assist Reprod Genet 2015 0.75
107 Assessing the potential for bias from non-response to a study follow-up interview: An example from the Agricultural Health Study. Am J Epidemiol 2017 0.75
108 [Induction of pulmonary precancerous lesions by tobacco-specific NNK in Wistar rats]. Zhongguo Fei Ai Za Zhi 2006 0.75
109 [Cyclooxygenase-2, inducible nitric oxide synthase protein expression and vasculature during experimental rat lung carcinogenesis]. Zhongguo Fei Ai Za Zhi 2003 0.75
110 Expression of inflammation related enzymes during experimental rat lung carcinogenesis. Zhonghua Zhong Liu Za Zhi 2002 0.75
111 Mild proteinuria in a patient with glomerularlimited intravascular large B-cell lymphoma. Clin Nephrol 2013 0.75